Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-14 3:21 pm Purchase |
2025-03-31 | 13G | Damon Inc. Common Stock DMN |
Ayrton Capital LLC | 17,075,660 9.990% |
17,075,660 (New Position) |
Filing History |
| 2025-05-14 3:19 pm Purchase |
2025-03-31 | 13G | AgriFORCE Growing Systems Ltd. AGRI |
Ayrton Capital LLC | 189,907 9.990% |
189,907 (New Position) |
Filing History |
| 2025-05-14 3:17 pm Sale |
2025-03-31 | 13G | The Glimpse Group, Inc. VRAR |
Ayrton Capital LLC | 1,040,200 4.940% |
-820,180 (-44.09%) |
Filing History |
| 2025-05-14 3:12 pm Sale |
2025-03-31 | 13G | Sidus Space, Inc. SIDU |
Ayrton Capital LLC | 241,546 1.310% |
-483,092 (-66.67%) |
Filing History |
| 2025-05-14 3:05 pm Purchase |
2025-03-31 | 13G | KWESST Micro Systems Inc. KWE |
Ayrton Capital LLC | 118,500 1.300% |
118,500 (New Position) |
Filing History |
| 2025-05-14 3:04 pm Unchanged |
2025-03-31 | 13G | Genius Group Limited GNS |
Ayrton Capital LLC | 1,953,162 2.940% |
0 (Unchanged) |
Filing History |
| 2025-05-14 3:02 pm Purchase |
2025-03-31 | 13G | 180 Life Sciences Corp. ATNF |
Ayrton Capital LLC | 247,105 4.550% |
247,105 (New Position) |
Filing History |
| 2025-05-14 3:00 pm Purchase |
2025-03-31 | 13G | WANG & LEE GROUP, Inc. WLGS |
Ayrton Capital LLC | 1,105,906 5.220% |
1,105,906 (New Position) |
Filing History |
| 2025-05-14 2:59 pm Purchase |
2025-03-31 | 13G | ReShape Lifesciences Inc. RSLS |
Ayrton Capital LLC | 200,000 5.710% |
200,000 (New Position) |
Filing History |
| 2025-05-14 2:57 pm Purchase |
2025-03-31 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP |
Ayrton Capital LLC | 163,480 9.990% |
163,480 (New Position) |
Filing History |
| 2025-05-14 2:55 pm Purchase |
2025-03-31 | 13G | Greenlane Holdings, Inc. GNLN |
Ayrton Capital LLC | 849,750 9.990% |
849,750 (New Position) |
Filing History |
| 2025-05-14 2:52 pm Purchase |
2025-03-31 | 13G | Azitra, Inc. AZTR |
Ayrton Capital LLC | 1,662,525 9.990% |
1,662,525 (New Position) |
Filing History |
| 2025-02-13 1:50 pm Purchase |
2024-12-31 | 13G | Imunon, Inc. IMNN |
Ayrton Capital LLC | 1,250,000 7.900% |
1,250,000 (New Position) |
Filing History |
| 2025-02-13 1:47 pm Sale |
2024-12-31 | 13G | Trio Petroleum Corp. TPET |
Ayrton Capital LLC | 38,496 0.100% |
-199,875 (-83.85%) |
Filing History |
| 2025-02-13 1:46 pm Sale |
2024-12-31 | 13G | ToughBuilt Industries, Inc. TBLT |
Ayrton Capital LLC | 65,812 4.400% |
-4,031,322 (-98.39%) |
Filing History |
| 2025-02-13 1:44 pm Sale |
2024-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Ayrton Capital LLC | 26,305 6.200% |
-612 (-2.27%) |
Filing History |
| 2025-02-13 1:42 pm Sale |
2024-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Ayrton Capital LLC | 774,100 9.900% |
-182,129 (-19.05%) |
Filing History |
| 2025-02-13 1:40 pm Purchase |
2024-12-31 | 13G | PAVmed Inc. PAVM |
Ayrton Capital LLC | 1,226,316 9.900% |
375,298 (+44.10%) |
Filing History |
| 2025-02-13 1:38 pm Sale |
2024-12-31 | 13G | Lucid Diagnostics Inc. LUCD |
Ayrton Capital LLC | 1,200,485 2.000% |
-3,755,213 (-75.78%) |
Filing History |
| 2025-02-13 1:35 pm Sale |
2024-12-31 | 13G | KWESST Micro Systems Inc. KWE |
Ayrton Capital LLC | 5,643 7.000% |
-50,786 (-90.00%) |
Filing History |